ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Late-Breaking Study Results of the Supreme HT™ Healing-Targeted DES Demonstrated Equivalent Outcomes with Exceptional Safety
November 18, 2020SINOMED® announced that Prof. Alexandra Lansky from the Yale School of Medicine, USA, presented data from its first inter-continental PIONEER III study comparing the safety and efficacy of the Supreme HT (Healing-Targeted) Drug-Eluting Stent ... -
Novo Nordisk’s diabetes pill clears cardiac safety hurdle
November 28, 2018Novo Nordisk is set to file its daily semaglutide type 2 diabetes pill after it cleared a phase 3 trial assessing its cardiac safety, with results showing it also reduced risk of cardiovascular and all-causes death in high-risk patients.
Pharma Sources Insight January 2025
